Hieke K - Search Results

1

Cost of illness from occupational hand eczema in Germany.

Diepgen TL, Scheidt R, Weisshaar E, John SM, Hieke K. Diepgen TL, et al. Among authors: hieke k. Contact Dermatitis. 2013 Aug;69(2):99-106. doi: 10.1111/cod.12038. Contact Dermatitis. 2013. PMID: 23869729

2

Cost-of-illness of patients with chronic hand eczema in routine care: results from a multicentre study in Germany.

Augustin M, Kuessner D, Purwins S, Hieke K, Posthumus J, Diepgen TL. Augustin M, et al. Among authors: hieke k. Br J Dermatol. 2011 Oct;165(4):845-51. doi: 10.1111/j.1365-2133.2011.10427.x. Br J Dermatol. 2011. PMID: 21623744

3

Association between visual acuity and medical and non-medical costs in patients with wet age-related macular degeneration in France, Germany and Italy.

Bandello F, Augustin A, Sahel JA, Benhaddi H, Negrini C, Hieke K, Berdeaux GH; MICMAC (MICro-economics of MACular degeneration) Study Group. Bandello F, et al. Among authors: hieke k. Drugs Aging. 2008;25(3):255-68. doi: 10.2165/00002512-200825030-00007. Drugs Aging. 2008. PMID: 18331076

4

Health economic analysis of fluoropyrimidine-based therapies of colorectal cancer from the perspective of statutory sickness funds.

Grothey A, Kleeberg UR, Stauch M, Hieke K. Grothey A, et al. Among authors: hieke k. Z Gastroenterol. 2005 Feb;43(2):155-61. doi: 10.1055/s-2004-813708. Z Gastroenterol. 2005. PMID: 15700205

5

Anxiety and depression prevalence rates in age-related macular degeneration.

Augustin A, Sahel JA, Bandello F, Dardennes R, Maurel F, Negrini C, Hieke K, Berdeaux G. Augustin A, et al. Among authors: hieke k. Invest Ophthalmol Vis Sci. 2007 Apr;48(4):1498-503. doi: 10.1167/iovs.06-0761. Invest Ophthalmol Vis Sci. 2007. PMID: 17389477

6

Evaluation of non-medical costs associated with visual impairment in four European countries: France, Italy, Germany and the UK.

Lafuma A, Brézin A, Lopatriello S, Hieke K, Hutchinson J, Mimaud V, Berdeaux G. Lafuma A, et al. Among authors: hieke k. Pharmacoeconomics. 2006;24(2):193-205. doi: 10.2165/00019053-200624020-00007. Pharmacoeconomics. 2006. PMID: 16460138

7

Epidemiology, medical outcomes and costs of catheter-related bloodstream infections in intensive care units of four European countries: literature- and registry-based estimates.

Tacconelli E, Smith G, Hieke K, Lafuma A, Bastide P. Tacconelli E, et al. Among authors: hieke k. J Hosp Infect. 2009 Jun;72(2):97-103. doi: 10.1016/j.jhin.2008.12.012. Epub 2009 Feb 25. J Hosp Infect. 2009. PMID: 19246122 Review.

8

Costs of treatment of colorectal cancer in different settings in Germany.

Hieke K, Kleeberg UR, Stauch M, Grothey A. Hieke K, et al. Eur J Health Econ. 2004 Oct;5(3):270-3. doi: 10.1007/s10198-003-0220-3. Eur J Health Econ. 2004. PMID: 15714348

9

Capecitabine (Xeloda) improves medical resource use compared with 5-fluorouracil plus leucovorin in a phase III trial conducted in patients with advanced colorectal carcinoma.

Twelves C, Boyer M, Findlay M, Cassidy J, Weitzel C, Barker C, Osterwalder B, Jamieson C, Hieke K; Xeloda Colorectal Cancer Study Group. Twelves C, et al. Among authors: hieke k. Eur J Cancer. 2001 Mar;37(5):597-604. doi: 10.1016/s0959-8049(00)00444-5. Eur J Cancer. 2001. PMID: 11290435 Clinical Trial.

10

Costs of drug delivery for CHOP, COP/CVP, and fludarabine: an international assessment.

Herold M, Hieke K. Herold M, et al. Among authors: hieke k. Value Health. 2003 Mar-Apr;6(2):167-74. doi: 10.1046/j.1524-4733.2003.00227.x. Value Health. 2003. PMID: 12641867 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

18 results

Search Page